SEPTEMBER 14, 2018

Drug for Skin Infections Promising in CF-Associated MRSA

By Gina Shaw

Telavancin (Vibativ, Astellas), a drug used to treat skin infections and hospital-acquired pneumonia, offers a potential option for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis (CF), according to a new study.